
Rebiyug L 75mg/20mg Capsule SR
Marketer
Yug Pharmaceuticals
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rebiyug L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication, Rebiyug L 75mg/20mg SR Capsules. This medication lowers stomach acid production and prevents its backflow into the esophagus. Dosage and duration are determined by your physician and should be followed precisely. Treatment should continue as directed; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms—most are transient. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. A high-fiber diet, avoidance of trigger foods, increased fluid intake, and regular exercise can enhance treatment outcomes. Prior to initiating treatment, disclose any kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding.
Uses of Rebiyug L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD) | Treating peptic ulcers | Managing irritable bowel syndrome (IBS)
Major Benefits of Rebiyug L 75mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rebiyug L 75mg/20mg sustained-release capsules on an empty stomach.
Common Side effects of Rebiyug L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Rebiyug L 75mg/20mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire capsule; avoid chewing, crushing, or fracturing it. Administer Rebiyug L 75mg/20mg SR Capsules on an empty stomach.
How Rebiyug L 75mg/20mg Capsule SR works:
Levosulpiride and rabeprazole, at dosages of 75mg and 20mg respectively, are combined in the sustained-release Rebiyug L capsule.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Rebiyug L 75mg/20mg SR Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rebiyug L 75mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Rebiyug L 75mg/20mg sustained-release capsules while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Rebiyug L 75mg/20mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Rebiyug L 75mg/20mg SR capsules in individuals with renal impairment. Medical advice is recommended. Preliminary findings, however, indicate that this medication should be administered cautiously to such patients.
LiverCAUTION
Patients with severe hepatic impairment should use Rebiyug L 75mg/20mg sustained-release capsules cautiously. Dosage modification of Rebiyug L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Rebiyug L 75mg/20mg Capsule SR :
Should you forget to take a Rebiyug L 75mg/20mg SR Capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebiyug L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
